US equities |
NVDA $221.30 ▼-3.16% MU $914.13 ▼-4.10% AAPL $342.96 ▲+0.50% AMD $570.82 ▼-5.73% META $737.54 ▼-3.27% MSFT $533.69 ▼-1.80% TSLA $367.16 ▼-2.15% SNDK $1,403.34 ▼-5.33%
FinancialContent

Moderna, Inc. - Common Stock (NQ:MRNA)

226.30 +10.05 (+4.65%)
Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
News headline image
AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test
From Biotech Insider
Via GlobeNewswire
News headline image
Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? ↗
Vertex raised its full-year outlook in Q2 with a growing pipeline across multiple disease areas. Moderna’s mRNA flu vaccine just cleared a key FDA hurdle with an expanding oncology pipeline behind it. 
Via The Motley Fool
Tuesday's pre-market session: top gainers and losers in the S&P500 index ↗
Via Chartmill
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026
From Moderna, Inc.
Via ACCESS Newswire
News headline image
Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick? ↗
Is bigger always better? Not necessarily. 
Via The Motley Fool
News headline image
These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys? ↗
Forget the "Magnificent Seven" in favor of the "Tremendous Three"? 
Via The Motley Fool
News headline image
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell? ↗
After a few years of stagnation, this stock is soaring. 
Via The Motley Fool
News headline image
Why Moderna Stock Surged Today ↗
The biotech could play a significant role in a national effort to combat cancer. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street ↗
Have Moderna’s shares risen too much, too fast? 
Via The Motley Fool
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. ↗
Via Chartmill
Discover which S&P500 stocks are making waves on Friday. ↗
Via Chartmill
News headline image
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026? ↗
Axsome is posting 65% revenue growth but burning cash, while Moderna's vaccine market is cooling yet its oncology pipeline carries transformative potential. 
Via The Motley Fool
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Is Now the Time to Cash Out of the S&P 500's Top 3 Stocks of 2026? ↗
These stocks have all soared more than 350% this year. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
Tuesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
A Soft Jobs Report Takes the Heat Off Rates, and Nvidia Closes In on $6 Trillion ↗
Via Chartmill
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Lu... 
Via StockStory
Topics Economy
News headline image
Stocks making big moves yesterday: United Therapeutics, Moderna, Jabil, Concentrix, and FactSet
Check out the companies making headlines yesterday: United Therapeutics (NASDAQ:UTHR): Biotechnology company United Therapeutics (NASDAQ:UTHR) rose by 13.6% ... 
Via StockStory
Topics Intellectual Property
News headline image
If I Could Tell Every New Investor 1 Thing About Building Wealth in the Stock Market, It's This ↗
New investors might be eager to jump in during a bull market. 
Via The Motley Fool
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
News headline image
Prediction: Moderna Stock Will Soar 100% by 2030 ↗
The company could enter a fresh growth phase. 
Via The Motley Fool
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Why Moderna (MRNA) Shares Are Falling Today
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6% in the morning session after Citigroup downgraded the company to Sell from Neutr... 
Via StockStory
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
Juan Andres to Return to Moderna as Chief Operating Officer Jerh Collins to Retire Following Four Years of Leadership at Moderna 
From Moderna, Inc.
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >